Results 181 to 190 of about 1,153,626 (336)

Use of monoclonal antibodies for detection of infectious pancreatic necrosis virus by the enzyme-linked immunosorbent assay (ELISA)

, 1990
Javier Domı́nguez, RP Hedrick, José Manuel Sánchez‐Vizcaíno   +2 more
openalex   +1 more source

Asymmetry of acetylcholinesterase and acetylcholine receptor in intact secretory vesicles from adrenal medulla [PDF]

, 1981
Casey, Chubb, Chubb, Gratzl, Gratzl, Mizobe, Rotundo, Rotundo, Somogyi, Wilson   +9 more
core   +1 more source

Precise Control of Drug Release in Machine Learning‐Designed Antibody‐Eluting Implants for Postoperative Scarring Inhibition in Glaucoma

Advanced Healthcare Materials, EarlyView.
We developed a micro‐sized, biocompatible implant for postoperative sustained delivery of anti‐fibrotic antibodies in glaucoma surgery. Machine learning‐guided optimization of polymer composition, implant geometry, and porosity enabled precise control of drug release.
Mengqi Qin, Wenbing Jiang, Kai Xin Thong, Zeynep Ulker, Brihitejas Patel, Cynthia Yu‐Wai‐Man   +5 more
wiley   +1 more source

Correction: Isolation, identification of porcine a rotavirus, and preparation of the monoclonal antibodies. [PDF]

Front Vet Sci
Hu Y, Wu H, Zha B, Song D, Wu X, Wu H.
europepmc   +1 more source

P2‐523: Therapeutic Monoclonal Antibodies against Abeta oligomers for Treatment of Alzheimer's disease [PDF]

, 2011
Ying Zhang
openalex   +1 more source

Monoclonal Antibody Therapy [PDF]

AAOHN Journal, 1987
openaire   +2 more sources

A Microphysiological Interface of Skeletal Myobundles and Inflamed Adipose Tissue for Recapitulating Muscle Dysfunction in an Obese Microenvironment

Advanced Healthcare Materials, EarlyView.
A human cell‐based microphysiological system integrates engineered muscle tissues with an inflamed adipose–macrophage niche to model obese microenvironment‐induced muscle dysfunction. Muscle contraction is quantified by pillar deflection coupled with computational stiffness estimation. Secretome and transcriptomic profiling reveal inflammation‐mediated
Seunggyu Kim, Tianxin Cao, Zhengpeng Wan, Jaesang Kim, Zhuxuan Li, Legairre A. Radden II, Rakesh Santhanam, Eunkyung Clare Ko, Tatsuya Osaki, Sarah Spitz, Hyunmin Moon, Maria Proestaki, Seokbeom Roh, Gyudo Lee, Jessie S. Jeon, Curtis R. Warren, Roger D. Kamm   +16 more
wiley   +1 more source

Development of monoclonal antibodies against E1 protein of Chikungunya virus. [PDF]

PLoS Negl Trop Dis
Wen K, Zhou Z, Xu P, Di B, Song J, Yang C, Zhan L, Zhao C, Xu M, Cai J, Yuan S, To KK, Feng W, Chan JF, Zhou H, Chen Y, Ding X.   +16 more
europepmc   +1 more source

Bioengineered Pancreatic Cancer Immunosuppressive Microenvironment Models for Screening Immunotherapies

Advanced Healthcare Materials, EarlyView.
Bioengineering tumor‐stroma pancreatic cancer models with potential to emulate the native immunosuppressive tumor microenvironment. Cancer‐on‐a‐bead models exhibited higher relevance for screening immunotherapies and modulating the protumoral PDAC microenvironment. ABSTRACT Pancreatic cancer is notably resistant to treatment, primarily due to its dense
Maria V. Monteiro, Margarida Henriques‐Pereira, Bruno M. Neves, Vítor M. Gaspar, João F. Mano   +4 more
wiley   +1 more source

Antigen binding triggers long-range conformational changes in monoclonal antibodies. [PDF]

Front Immunol
Bianchi D, Saporiti S, Palinsky W, Ben Mariem O, Rossi M, Eberini I, Centola F.   +6 more
europepmc   +1 more source